Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 01, 2021
- Source ID
- 10.1016/j.coviro.2021.06.003
Entities
People
- George R. Painter
- Michael G. Natchus
- Oren J. Cohen
- Wendy Holman
- Wendy P Painter
Organizations
- Defense Threat Reduction Agency
- National Institute of Allergy and Infectious Diseases